244 related articles for article (PubMed ID: 30179273)
1. Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study.
Goselink RJM; Schreuder THA; van Alfen N; de Groot IJM; Jansen M; Lemmers RJLF; van der Vliet PJ; van der Stoep N; Theelen T; Voermans NC; van der Maarel SM; van Engelen BGM; Erasmus CE
Ann Neurol; 2018 Nov; 84(5):627-637. PubMed ID: 30179273
[TBL] [Abstract][Full Text] [Related]
2. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
[TBL] [Abstract][Full Text] [Related]
3. Natural History of Facioscapulohumeral Dystrophy in Children: A 2-Year Follow-up.
Dijkstra JN; Goselink RJM; van Alfen N; de Groot IJM; Pelsma M; van der Stoep N; Theelen T; van Engelen BGM; Voermans NC; Erasmus CE
Neurology; 2021 Nov; 97(21):e2103-e2113. PubMed ID: 34675094
[TBL] [Abstract][Full Text] [Related]
4. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
[TBL] [Abstract][Full Text] [Related]
5. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.
Ruggiero L; Mele F; Manganelli F; Bruzzese D; Ricci G; Vercelli L; Govi M; Vallarola A; Tripodi S; Villa L; Di Muzio A; Scarlato M; Bucci E; Antonini G; Maggi L; Rodolico C; Tomelleri G; Filosto M; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Moggio M; Mongini T; Siciliano G; Santoro L; Tupler R
JAMA Netw Open; 2020 May; 3(5):e204040. PubMed ID: 32356886
[TBL] [Abstract][Full Text] [Related]
7. Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.
Goselink RJM; Voermans NC; Okkersen K; Brouwer OF; Padberg GW; Nikolic A; Tupler R; Dorobek M; Mah JK; van Engelen BGM; Schreuder THA; Erasmus CE
Neuromuscul Disord; 2017 Dec; 27(12):1077-1083. PubMed ID: 29102079
[TBL] [Abstract][Full Text] [Related]
8. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.
Nikolic A; Ricci G; Sera F; Bucci E; Govi M; Mele F; Rossi M; Ruggiero L; Vercelli L; Ravaglia S; Brisca G; Fiorillo C; Villa L; Maggi L; Cao M; D'Amico MC; Siciliano G; Antonini G; Santoro L; Mongini T; Moggio M; Morandi L; Pegoraro E; Angelini C; Di Muzio A; Rodolico C; Tomelleri G; Grazia D'Angelo M; Bruno C; Berardinelli A; Tupler R
BMJ Open; 2016 Jan; 6(1):e007798. PubMed ID: 26733561
[TBL] [Abstract][Full Text] [Related]
9. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
[TBL] [Abstract][Full Text] [Related]
10. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
[TBL] [Abstract][Full Text] [Related]
11. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
[TBL] [Abstract][Full Text] [Related]
12. Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1.
Park HJ; Hong JM; Lee JH; Lee HS; Shin HY; Kim SM; Ki CS; Lee JH; Choi YC
Neuromuscul Disord; 2015 Nov; 25(11):859-64. PubMed ID: 26319123
[TBL] [Abstract][Full Text] [Related]
13. A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1.
Xiao T; Yang H; Gan S; Wu L
Medicine (Baltimore); 2021 Nov; 100(47):e27907. PubMed ID: 34964760
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and genetical features of Japanese early-onset facioscapulohumeral muscular dystrophy].
Yamanaka G; Goto K; Hayashi YK; Miyajima T; Hoshika A; Arahata K
No To Hattatsu; 2002 Jul; 34(4):318-24. PubMed ID: 12134683
[TBL] [Abstract][Full Text] [Related]
16. Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy.
Pastorello E; Cao M; Trevisan CP
Clin Neurol Neurosurg; 2012 Apr; 114(3):230-4. PubMed ID: 22079131
[TBL] [Abstract][Full Text] [Related]
17. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.
Wohlgemuth M; Lemmers RJ; Jonker M; van der Kooi E; Horlings CG; van Engelen BG; van der Maarel SM; Padberg GW; Voermans NC
Neurology; 2018 Jul; 91(5):e444-e454. PubMed ID: 29997197
[TBL] [Abstract][Full Text] [Related]
18. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation.
Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H
Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.
Nikolic A; Jones TI; Govi M; Mele F; Maranda L; Sera F; Ricci G; Ruggiero L; Vercelli L; Portaro S; Villa L; Fiorillo C; Maggi L; Santoro L; Antonini G; Filosto M; Moggio M; Angelini C; Pegoraro E; Berardinelli A; Maioli MA; D'Angelo G; Di Muzio A; Siciliano G; Tomelleri G; D'Esposito M; Della Ragione F; Brancaccio A; Piras R; Rodolico C; Mongini T; Magdinier F; Salsi V; Jones PL; Tupler R
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290091
[TBL] [Abstract][Full Text] [Related]
20. Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review.
Chen TH; Wu YZ; Tseng YH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
